The Centers for Disease Control and Prevention (CDC) has issued an update on influenza cases for week 30 ending July 28, 2012 in the 2011-2012 influenza season.
U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states and Washington, D.C. report to CDC the number of respiratory specimens tested for influenza and the number positive by influenza type and subtype. Region specific data can be found at http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html.
Novel Influenza A Virus: Twelve human infections with novel influenza A viruses were detected in three states (Hawaii [1], Indiana [1], and Ohio [10]). The 12 persons were infected with influenza A (H3N2) variant viruses similar to those identified in cases that occurred previously in 2011 and 2012. At this time no ongoing human-to-human transmission has been identified and all 12 cases have reported close contact with swine prior to illness onset. While the viruses identified in these cases are genetically related, separate swine exposure events in each state are associated with infection and there is no indication that the cases in different states are related. Public health and agriculture officials are investigating the extent of disease among humans and swine, and additional
cases are likely to be identified as the investigation continues.
The CDC is required to report all cases of human infection with novel (non-human) influenza viruses including influenza viruses of swine origin to the World Health Organization (WHO) as part of the International Health Regulations (IHR). Domestically, CDC reports these cases in this report and on its website. Early identification and investigation of human infections with novel influenza A viruses is critical in order to evaluate the extent of the outbreak and possible human-to-human transmission. Additional information on influenza in swine, variant influenza infection in humans, and strategies to interact safely with livestock can be found at http://www.cdc.gov/flu/swineflu/influenza-variant-viruses-h3n2v.htm.
Pneumonia and Influenza (P&I) Mortality Surveillance: During week 30, 5.6 percent of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 6.6 percent for week 30.
Influenza-Associated Pediatric Mortality: No influenza-associated pediatric deaths were reported to the CDC during week 30. A total of 34 influenza-associated pediatric deaths have been reported during the 2011-2012 season. Additional data can be found at: http://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html.
Influenza-Associated Hospitalizations: The Influenza Surveillance Network (FluSurv-NET) conducts all age population-based surveillance for laboratory-confirmed influenza-related hospitalizations in select counties in the Emerging Infections Program (EIP) states and Influenza Hospitalization Surveillance Project (IHSP) states. Additional FluSurv-NET data can be found at: http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html
Outpatient Illness Surveillance: Nationwide during week 30, 0.8 percent of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.4 percent. (ILI is defined as fever (temperature of 100°F [37.8°C] or greater) and cough and/or sore throat.) Region specific data can be found at http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.